Innovative Contraceptive Technology Agile Therapeutics leverages proprietary transdermal patch technology, Skinfusion®, to deliver low-dose contraceptive options. This innovative delivery method offers an alternative to daily pills and long-acting devices, presenting opportunities to expand product awareness and adoption among women seeking convenient and discreet birth control solutions.

Strategic Partnerships Expansion The company's recent collaborations with FPA Women’s Health, vitaCare, and Exeltis USA broaden distribution channels and access points for Twirla®. These partnerships create potential sales avenues through clinics, pharmacies, and women’s health providers, enhancing market penetration.

Recent Acquisition Growth Insud Pharma’s acquisition of Agile Therapeutics for $45 million signals increased investment and confidence in the company's contraceptive portfolio. This growth capital can be leveraged to accelerate sales efforts and fuel further product development targeted at unmet needs in women's health.

Market Focus on Women’s Health With a dedicated focus on women’s healthcare and contraceptive solutions, Agile Therapeutics is well-positioned to meet rising demand for non-daily, user-friendly birth control options. This trend aligns with consumers' preferences for convenience and autonomy, opening sales opportunities with OB-GYN clinics, pharmacies, and direct-to-consumer channels.

Digital and Technological Presence Utilizing advanced digital tools such as Drupal, PHP, and cloud platforms, Agile Therapeutics maintains a modern and scalable online presence. Enhancing digital engagement and education initiatives can further boost product awareness and foster relationships with healthcare providers and potential customers.